These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29232638)

  • 1. Engineering a self-sufficient Mycobacterium tuberculosis CYP130 by gene fusion with the reductase-domain of CYP102A1 from Bacillus megaterium.
    Ortega Ugalde S; Luirink RA; Geerke DP; Vermeulen NPE; Bitter W; Commandeur JNM
    J Inorg Biochem; 2018 Mar; 180():47-53. PubMed ID: 29232638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the interaction between human P450 3A4 and B. megaterium reductase via engineered loops.
    Castrignanò S; D'Avino S; Di Nardo G; Catucci G; Sadeghi SJ; Gilardi G
    Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):116-125. PubMed ID: 28734977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a thermostable cytochrome P450 chimera derived from self-sufficient mesophilic parents.
    Eiben S; Bartelmäs H; Urlacher VB
    Appl Microbiol Biotechnol; 2007 Jul; 75(5):1055-61. PubMed ID: 17468867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
    Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
    Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P450
    Beyer N; Kulig JK; Bartsch A; Hayes MA; Janssen DB; Fraaije MW
    Appl Microbiol Biotechnol; 2017 Mar; 101(6):2319-2331. PubMed ID: 27900443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Process limitations of a whole-cell P450 catalyzed reaction using a CYP153A-CPR fusion construct expressed in Escherichia coli.
    Lundemo MT; Notonier S; Striedner G; Hauer B; Woodley JM
    Appl Microbiol Biotechnol; 2016 Feb; 100(3):1197-1208. PubMed ID: 26432459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering human cytochrome P450 enzymes into catalytically self-sufficient chimeras using molecular Lego.
    Dodhia VR; Fantuzzi A; Gilardi G
    J Biol Inorg Chem; 2006 Oct; 11(7):903-16. PubMed ID: 16862439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium tuberculosis CYP130: crystal structure, biophysical characterization, and interactions with antifungal azole drugs.
    Ouellet H; Podust LM; de Montellano PR
    J Biol Chem; 2008 Feb; 283(8):5069-80. PubMed ID: 18089574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of inter-domain dynamics and surrounding environment flexibility on the direct electrochemistry and electrocatalysis of self-sufficient cytochrome P450 3A4-BMR chimeras.
    Castrignanò S; Di Nardo G; Sadeghi SJ; Gilardi G
    J Inorg Biochem; 2018 Nov; 188():9-17. PubMed ID: 30098472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The full-length cytochrome P450 enzyme CYP102A1 dimerizes at its reductase domains and has flexible heme domains for efficient catalysis.
    Zhang H; Yokom AL; Cheng S; Su M; Hollenberg PF; Southworth DR; Osawa Y
    J Biol Chem; 2018 May; 293(20):7727-7736. PubMed ID: 29618513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
    Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
    Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric cytochromes P450 engineered by domain swapping and random mutagenesis for producing human metabolites of drugs.
    Kang JY; Ryu SH; Park SH; Cha GS; Kim DH; Kim KH; Hong AW; Ahn T; Pan JG; Joung YH; Kang HS; Yun CH
    Biotechnol Bioeng; 2014 Jul; 111(7):1313-22. PubMed ID: 24474032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic fusion of P450 BM3 and formate dehydrogenase towards self-sufficient biocatalysts with enhanced activity.
    Kokorin A; Parshin PD; Bakkes PJ; Pometun AA; Tishkov VI; Urlacher VB
    Sci Rep; 2021 Nov; 11(1):21706. PubMed ID: 34737365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for the properties of two single-site proline mutants of CYP102A1 (P450BM3).
    Whitehouse CJ; Yang W; Yorke JA; Rowlatt BC; Strong AJ; Blanford CF; Bell SG; Bartlam M; Wong LL; Rao Z
    Chembiochem; 2010 Dec; 11(18):2549-56. PubMed ID: 21110374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regioselective hydroxylation of 17β-estradiol by mutants of CYP102A1 from Bacillus megaterium.
    Cha GS; Ryu SH; Ahn T; Yun CH
    Biotechnol Lett; 2014 Dec; 36(12):2501-6. PubMed ID: 25129047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity isolation and characterization of cytochrome P450 102 (BM-3) from barbiturate-induced Bacillus megaterium.
    Black SD; Linger MH; Freck LC; Kazemi S; Galbraith JA
    Arch Biochem Biophys; 1994 Apr; 310(1):126-33. PubMed ID: 8161195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein engineering of the cytochrome P450 monooxygenase from Bacillus megaterium.
    Urlacher VB; Schmid RD
    Methods Enzymol; 2004; 388():208-24. PubMed ID: 15289074
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolved CYP102A1 (P450BM3) variants oxidise a range of non-natural substrates and offer new selectivity options.
    Whitehouse CJ; Bell SG; Tufton HG; Kenny RJ; Ogilvie LC; Wong LL
    Chem Commun (Camb); 2008 Feb; (8):966-8. PubMed ID: 18283351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics and activation parameters for oxidations of styrene by Compounds I from the cytochrome P450(BM-3) (CYP102A1) heme domain and from CYP119.
    Yuan X; Wang Q; Horner JH; Sheng X; Newcomb M
    Biochemistry; 2009 Sep; 48(38):9140-6. PubMed ID: 19708688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key mutations alter the cytochrome P450 BM3 conformational landscape and remove inherent substrate bias.
    Butler CF; Peet C; Mason AE; Voice MW; Leys D; Munro AW
    J Biol Chem; 2013 Aug; 288(35):25387-25399. PubMed ID: 23828198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.